Ampio Pharmaceuticals, Inc.
(Other OTC/NBB : AMPE)

( )
AMPE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.26%165.190.7%$1305.30m
LLYEli Lilly & Co. 0.57%331.781.1%$1072.82m
ABBVAbbVie, Inc. 0.94%143.331.9%$877.03m
PFEPfizer Inc. -0.47%44.250.9%$815.29m
BMYBristol-Myers Squibb Co. 0.34%71.451.0%$767.68m
MRKMerck & Co., Inc. 0.01%88.400.7%$706.05m
AZNAstraZeneca Plc -0.54%56.731.0%$402.73m
ALNYAlnylam Pharmaceuticals, Inc. -0.11%201.028.2%$225.00m
GSKGSK Plc -1.01%30.400.3%$210.45m
NVSNovartis AG -1.11%77.360.2%$209.93m
IDXXIDEXX Laboratories, Inc. 0.44%350.123.9%$189.64m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$183.92m
HZNPHorizon Therapeutics Plc 1.35%67.055.4%$182.38m
NVONovo Nordisk A/S 0.63%106.040.1%$132.75m
SRPTSarepta Therapeutics, Inc. -0.76%110.6212.4%$132.70m

Company Profile

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.